<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>ETHNOPHARMACOLOGICAL RELEVANCE: <z:chebi fb="5" ids="47916">Flavonoids</z:chebi>, extracted from the leaves of Diospyros kaki, are the main therapeutic components of NaoXingQing (NXQ), a potent and patented Chinese herbal remedy widely used in China for the treatment of <z:e sem="disease" ids="C0038454" disease_type="Disease or Syndrome" abbrv="">apoplexy</z:e> syndrome </plain></SENT>
<SENT sid="1" pm="."><plain>AIM OF THE STUDY: To investigate the neuroprotective effects of FLDK-P70, a standardized <z:chebi fb="5" ids="47916">flavonoid</z:chebi> extract, using in vivo rat models of both focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion (I/R) injury induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) and on transient global <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> induced by four-vessel occlusion (4-VO) </plain></SENT>
<SENT sid="2" pm="."><plain>We also aim to examine the effects of FLDK-P70 on <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>-induced cell injury of hippocampal neurons as well as on <z:mp ids='MP_0005039'>hypoxia</z:mp>-induced injury of cortical neurons in primary cell culture </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIALS AND METHODS AND RESULTS: Administration of FLDK-P70 for 12 days (40, 80 mg/kg body weight, p.o., 5 days before and 7 days after 4-VO) increased the survival of hippocampal CA1 pyramidal neurons after transient global <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Similarly, administration of FLDK-P70 for 7 days (40, 80 mg/kg body weight, p.o., 3 days before and 4 days after MCAO) significantly reduced the lesion of the insulted brain hemisphere and improved the neurological behavior of rats </plain></SENT>
<SENT sid="5" pm="."><plain>In primary rat hippocampal neuronal cultures, pretreatment with FLDK-P70 (5, 10 microg/ml) protected neurons from <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>-induced excitotoxic neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in a dose-dependent manner </plain></SENT>
<SENT sid="6" pm="."><plain>In primary rat cerebral cortical neuronal culture, pretreatment with FLDK-P70 (25, 100 microg/ml) also reduced <z:mp ids='MP_0005039'>hypoxia</z:mp>-reoxygen induced neuronal <z:hpo ids='HP_0011420'>death</z:hpo> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in a dose-dependent manner </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These in vivo and in vitro results suggest that FLDK-P70 significantly protects rats from MCAO and 4-VO ischemic injury in vivo and protects hippocampal neurons from <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>-induced excitotoxic injury as well as cortical neurons from <z:mp ids='MP_0005039'>hypoxia</z:mp>-induced injury in vitro </plain></SENT>
<SENT sid="8" pm="."><plain>The mechanisms of these effects may be due to the antioxidative activity of the <z:chebi fb="5" ids="47916">flavonoids</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>These results convincingly demonstrate that FLDK-P70 may be useful for the prevention and treatment of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury and other related <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> </plain></SENT>
</text></document>